Vanguard Group’s ArriVent BioPharma AVBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $32.3M | Sell |
1,483,540
-19,818
| -1% | -$431K | ﹤0.01% | 2328 |
|
|
2025
Q1 | $27.8M | Buy |
1,503,358
+86,067
| +6% | +$1.59M | ﹤0.01% | 2353 |
|
|
2024
Q4 | $37.8M | Buy |
1,417,291
+71,741
| +5% | +$1.91M | ﹤0.01% | 2282 |
|
|
2024
Q3 | $31.6M | Buy |
1,345,550
+694,476
| +107% | +$16.3M | ﹤0.01% | 2381 |
|
|
2024
Q2 | $12.1M | Buy |
651,074
+2,339
| +0.4% | +$43.4K | ﹤0.01% | 2809 |
|
|
2024
Q1 | $11.6M | Buy |
+648,735
| New | +$11.6M | ﹤0.01% | 2867 |
|